Epidemiology of smoking-induced cardiovascular disease

Progress in Cardiovascular Diseases

Volumn 46, Issue 1, 2003, Pages 11-29

  Burns, David M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NICOTINE; TAR;

ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CIGARETTE SMOKING; HUMAN; ISCHEMIC HEART DISEASE; PREVALENCE; REVIEW; RISK ASSESSMENT; SMOKING CESSATION; SMOKING HABIT; THROMBOSIS;

EID: 0042467881     PISSN: 00330620     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0033-0620(03)00079-3     Document Type: Article

References (212)

1. U.S. Department of Health, Education, and Welfare: The Health Consequences of Smoking: A Report to the Surgeon General. Washington, DC, U.S. Department of Health, Education, and Welfare, Public Health Service, Health Services and Mental Health Administration, Office on Smoking and Health, DHEW Publication No. (HSM) 71-7513, 1971
2. U.S. Department of Health, Education, and Welfare: Smoking and Health. A Report of the Surgeon General. Washington, DC, U.S. Department of Health, Education, and Welfare, Public Health Service, Office of the Assistant Secretary for Health, Office on Smoking and Health, DHEW Publication No. (PHS) 79-50066, 1979
3. U.S. Department of Health and Human Services: The Health Consequences of Smoking: Cardiovascular Disease. A Report of the Surgeon General. Atlanta, GA, U.S. Department of Health and Human Services, Public Health Services, Office of the Surgeon General, Office of Smoking and Health, DHHS Publication No. (PHS) 84-50204, p 388, 1983
4. U.S. Department of Health and Human Services: Women and Smoking: A Report of the Surgeon General. Atlanta, GA, U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking Health, 2001
5. U.S. Department of Health and Human Services: The Health Consequences of Tobacco Use: A Report of the Surgeon General. Atlanta, GA, U.S. Department of Health and Human Services, Public Health Service Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 2003
6. Friedman GD, Dales LG, Ury HK: Mortality in middle-aged smokers and nonsmokers. N Engl J Med 300: 213-217, 1979
7. Neaton JD, Wentworth D: Multiple Risk Factor Intervention Trial Research Group. Serum cholesterol, blood pressure, cigarette smoking, and death from coronary heart disease. Overall findings and differences by age for 316,099 white men. Arch Intern Med 152:56-64, 1992
8. Shaper AG, Pocock SJ, Walker M, et al: Risk factors for ischaemic heart disease: The prospective phase of the British Regional Heart Study. J Epidemiol Community Health 39:197-209, 1985
9. Criqui MH, Cowan LD, Tyroler HA, et al: Lipoproteins as mediators for the effects of alcohol consumption and cigarette smoking on cardiovascular mortality: Results form the Lipid Research Clinics Follow-up Study. Am J Epidemiol 126:629-637, 1987
10. Ragland DR, Brand RJ: Coronary heart disease mortality in the Western Collaborative Group Study. Follow-up experience of 22 years. Am J Epidemiol 127:462-475, 1988
11. Shaten BJ, Kuller LH, Neaton JD: Association between baseline risk factors, cigarette smoking, and CHD mortality after 10.5 years. MRFIT Research Group. Prev Med 20:655-659, 1991
12. Gartside PS, Wang P, Glueck CJ: Prospective assessment of coronary heart disease risk factors: The NHANES I epidemiologic follow-up study (NHEFS) 16-year follow-up. J Am Coll Nutr 17:263-269, 1998
13. Wannamethee SG, Shaper AG, Walker M, et al: Lifestyle and 15-year survival free of heart attack, stroke, and diabetes in middle-aged British men. Arch Intern Med 158:2433-1440, 1998
14. Jacobs DR Jr, Adachi H, Mulder I, et al: Cigarette smoking and mortality risk: Twenty-five-year follow-up of the Seven Countries Study. Arch Intern Med 159:733-740, 1999
15. Freund KM, Belanger AJ, D'Agostino RB, et al: The health risks of smoking. The Framingham Study: 34 years of follow-up. Ann Epidemiol 3:417-424, 1993
16. Cremer P, Nagel D, Mann H, et al: Ten-year follow-up results from the Goettingen Risk, Incidence and Prevalence Study (GRIPS). I. Risk factors for myocardial infarction in a cohort of 5790 men. Atherosclerosis 129:221-230, 1997
17. Blanco-Cedres L, Daviglus ML, Garside DB, et al: Relation of cigarette smoking to 25-year mortality in middle-aged men with low baseline serum cholesterol: The Chicago Heart Association Detection Project in Industry. Am J Epidemiol 155:354-360, 2002
18. Pooling Project Research Group: Relationship of blood pressure, serum cholesterol, smoking habit, relative weight and ECG abnormalities to incidence of major coronary events: Final report of the pooling project. J Chronic Dis 31:201-306, 1978
19. U.S. Department of Health and Human Services: The Health Benefits of Smoking Cessation. A Report of the Surgeon General. Atlanta, GA, U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control, Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, DHHS Publication No. (CDC) 90-8416, 1990
20. Strong JP, Richards ML: Cigarette smoking and atherosclerosis in autopsied men. Atherosclerosis 23:451-476, 1976
21. Solberg LA, Strong JP: Risk factors and atherosclerotic lesions. A review of autopsy studies. Arteriosclerosis 3:187-198, 1983
22. Auerbach O, Garfinkel L: Atherosclerosis and aneurysm of aorta in relation to smoking habits and age. Chest 78:805-809, 1980
23. Auerbach O, Hammond EC, Garfinkel L: Smoking in relation to atherosclerosis of the coronary arteries. N Engl J Med 272:775-779, 1965
24. Auerbach O, Hammond EC, Garfinkel L, et al: Thickness of walls of myocardial arterioles in relation to smoking and age. Arch Environ Health 22:20-27, 1971
25. Auerbach O, Carter HW, Garfinkel L, et al: Cigarette smoking and coronary artery disease. A macroscopic and microscopic study. Chest 70:697-705, 1976
26. Zieske AW, Takei H, Fallon KB, et al: Smoking and atherosclerosis in youth. Atherosclerosis 144:403-408, 1999
27. Rhoads GG, Blackwelder WC, Stemmermann GN, et al: Coronary risk factors and autopsy findings in Japanese-American men. Lab Invest 38:304-311, 1978
28. Holme I, Enger SC, Helgeland A, et al: Risk factors and raised atherosclerotic lesions in coronary and cerebral arteries. Statistical analysis from the Oslo study. Arteriosclerosis 1:250-256, 1981
29. Sorlie PD, Garcia-Palmieri MR, Castillo-Staab MI, et al: The relation of antemortem factors to atherosclerosis at autopsy. The Puerto Rico Heart Health Program. Am J Pathol 103:345-352, 1981
30. Solberg LA, Strong JP, Holme I, et al: Stenoses in the coronary arteries. Relation to atherosclerotic lesions, coronary heart disease and risk factors. The Oslo Study. Lab Invest 53:648-655, 1985
31. Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group: Relationship of atherosclerosis in young men to serum lipoprotein cholesterol concentrations and smoking. A prelimmary report from the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. JAMA 264:3018-3024, 1990
32. McGill HC Jr, McMahan CA, Herderick EE, et al: Effects of coronary heart disease risk factors on atherosclerosis of selected regions of the aorta and right coronary artery. PDAY Research Group. Pathobiological Determinants of Atherosclerosis in Youth. Arterioscler Thromb Vasc Biol 20:836-845, 2000
33. McGill HC Jr, McMahan CA, Malcom GT, et al: Effects of serum lipoproteins and smoking on atherosclerosis in young men and women. The PDAY Research Group. Pathobiological Determinants of Atherosclerosis in Youth. Arterioscler Thromb Vasc Biol 17:95-106, 1997
34. McGill HC Jr, McMahan CA, Zieske AW, et al: Effects of nonlipid risk factors on atherosclerosis in youth with a favorable lipoprotein profile. Circulation 103:1546-1550, 2001
35. Berenson GS, Srinivasan SR, Bao W, et al: Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study. N Engl J Med 338:1650-1656, 1998
36. Weintraub WS, Klein LW, Seelaus PA, et al: Importance of total life consumption of cigarettes as a risk factor for coronary artery disease. Am J Cardiol 55:669-672, 1985
37. Vander Zwaag R, Lemp GF, Hughes JP, et al: The effect of cigarette smoking on the pattern of coronary atherosclerosis. A case-control study. Chest 94:290-295, 1988
38. Herbert WH: Cigarette smoking and arteriographically demonstrable coronary artery disease. Chest 67:49-52, 1975
39. Reed D, Yano K: Predictors of arteriographically defined coronary stenosis in the Honolulu Heart Program. Comparisons of cohort and arteriography series analyses. Am J Epidemiol 134:111-122, 1991
40. Moise A, Theroux P, Taeymans Y, et al: Factors associated with progression of coronary artery disease in patients with normal or minimally narrowed coronary arteries. Am J Cardiol 56:30-34, 1985
41. Waters D, Lesperance J, Gladstone P, et al: Effects of cigarette smoking on the angiographic evolution of coronary atherosclerosis. A Canadian Coronary Atherosclerosis Intervention Trial (CCAIT) Substudy. CCAIT Study Group. Circulation 94:614-621, 1996
42. Thun M, Myers D, Day-Lally C, et al: Age and the exposure-response relationships between cigarette smoking and premature death in Cancer Prevention Study II, in Smoking and Tobacco Control Monograph 8 Changes in Cigarette-Related Disease Risks and Their Implications for Prevention and Control. Burns D, Garfinkel L, Samet JM, eds. Bethesda, MD, National Institutes of Health, National Cancer Institute, 1997, pp 383-476
43. Rosengren A, Wilhelmsen L, Wedel H: Coronary heart disease, cancer and mortality in male middle-aged light smokers. J Intern Med 231:357-362, 1992
44. Doll R, Peto R: Mortality in relation to smoking: 20 years' observations on male British doctors. Br Med J 2:1525-1536, 1976
45. Miettinen OS, Neff RK, Jick H: Cigarette-smoking and nonfatal myocardial infarction: Rate ratio in relation to age, sex and predisposing conditions. Am J Epidemiol 103:30-36, 1976
46. Willett WC, Green A, Stampfer MJ, et al: Relative and absolute excess risks of coronary heart disease among women who smoke cigarettes. N Engl J Med 317:1303-1309, 1987
47. Benowitz NL: Biomarkers of cigarette smoking. National Cancer Institute. The FTC Cigarette Test Method for Determining Tar, Nicotine, and Carbon Monoxide Yields of U.S. Cigarettes. Smoking and Tobacco Control Monograph Number 7. Atlanta, GA, U.S. Department of Health and Human Services, National Institutes of Health, National Cancer Institute, National Institutes of Health Publication No. 96-4028, pp 93-111, 1996
48. Law MR, Morris JK, Watt HC, et al: The dose-response relationship between cigarette consumption, biochemical markers and risk of lung cancer. Br J Cancer 75:1690-1693, 1997
49. Burns DM, Shanks TG, Major JM, et al: Smoking lower yield cigarettes and disease risks, in Burns DM, Benowitz NL (eds): Risks Associated with Smoking Cigarettes with Low Machin-Measured Yields of Tar and Nicotine. Smoking and Tobacco Control Monograph, No. 13. Atlanta, GA, U.S. Department of Health and Human Services, PHS, National Institutes of Health, National Cancer Institute, National Institutes of Health Pub. No. 02-5074, 2001
50. National Cancer Institute: Risks associated with smoking cigarettes with low machine yields of tar and nicotine. Smoking and Tobacco Control Monograph No. 13. Bethesda, MD, U.S. Department of Health and Human Services, National Cancer Institute, 2001
51. Kuller LH: Cigarette smoking and mortality. MRFIT Research Group. Prev Med 20:638-654, 1991
52. Tverdal A: Calculation of risk for the development of acute myocardial infarction in the normal population based on long-term follow-up studies: Smokers compared with non-smokers. J Cardiovasc Risk 6:287-291, 1999
53. Burns D, Shanks T, Choi W, et al: The American Cancer Society Cancer Prevention Study #1, 12-year follow-up on one million men and women, in Burns D, Garfinkel L, Samet J (eds): Changes in Cigarette-Related Disease Risks and Their Implication for Prevention and Control. Smoking and Tobacco Control, Monograph No. 8. Atlanta, GA, U.S. Department of Health and Human Services, National Institutes of Health, National Cancer Institute, pp 113-304, 1997
54. Castelli WB, Wilson PW, Levy D, et al: Cardiovascular risk factors in the elderly. Am J Cardiol 63:12H-19H, 1989
55. Welin L, Eriksson H, Larsson B, et al: Risk factors for coronary heart disease during 25 years of follow-up. The study of men born in 1913. Cardiology 82:223-228, 1993
56. Harris T, Cook EF, Kannel WB: Proportional hazards analysis of risk factors for coronary heart disease in individuals aged 65 or older. J Am Geriatric Soc 36:1023-1028, 1988
57. Benfante R, Reed D, Frank J: Does cigarette smoking have an independent effect on coronary heart disease incidence in the elderly? Am J Public Health 81:897-899, 1991
58. Nissinen A, Pekkanen J, Porath A, et al: Risk factors for cardiovascular disease among 55 to 74 year-old Finnish men: A 10-year follow-up. Ann Med 21:239-240, 1989
59. Frost PH, Davis BR, Burlando AJ, et al: Coronary heart disease risk factors in men and women aged 60 years and older: Findings from the Systolic Hypertension in the Elderly Program. Circulation 94:26-34, 1996
60. Houterman S, Boshuizen HC, Verschuren WM, et al: Predicting cardiovascular risk in the elderly in different European countries. Eur Heart J 23:294-300, 2002
61. Jajich CL, Ostfeld AM, Freeman DH Jr: Smoking and coronary heart disease mortality in the elderly. JAMA 252:2831-2834, 1984
62. Hermanson B, Omenn GS, Kronmal RA, et al: Beneficial six-year outcome of smoking cessation in older men and women with coronary artery disease. Results from the CASS registry. N Engl J Med 319: 1365-1369, 1988
63. Kanitz MG, Giovannucci SJ, Jones JS, et al: Myocardial infarction in young adults: Risk factors and clinical features. J Emerg Med 14:139-145, 1996
64. Navas-Nacher EL, Colangelo L, Beam C, et al: Risk factors for coronary heart disease in men 18 to 39 years of age. Ann Intern Med 134:433-439, 2001
65. Gordon T, Kannel WB, McGee D, et al: Death and coronary attacks in men after giving up cigarette smoking. Lancet 2:1345-1348, 1974
66. Aberg A, Bergstrand R, Johansson S, et al: Cessation of smoking after myocardial infarction. Effects on mortality after 10 years. Br Heart J 49:416-422, 1983
67. Qiao Q, Tervahauta M, Nissinen A, et al: Mortality from all causes and from coronary heart disease related to smoking and changes in smoking during a 35-year follow-up of middle-aged Finnish men. Eur Heart J 21:1621-1626, 2000
68. Dagenais GR, Robitaille NM, Lupien PJ, et al: First coronary heart disease event rates in relation to major risk factors: Quebec cardiovascular study. Can J Cardiol 6:274-280, 1990
69. Omenn GS, Anderson KW, Kronmal RA, et al: The temporal pattern of reduction of mortality risk after smoking cessation. Am J Prev Med 6:251-257, 1990
70. Kawachi I, Colditz GA, Stampfer MJ, et al: Smoking cessation in relation to total mortality rates in women. A prospective cohort study. Ann Intern Med 119:992-1000, 1993
71. Kawachi I, Colditz GA, Stampfer MJ, et al: Smoking cessation and time course of decreased risks of coronary heart disease in middle-aged women. Arch Intern Med 154:169-175, 1994
72. Daly LE, Mulcahy R, Graham IM, et al: Long term effect on mortality of stopping smoking after unstable angina and myocardial infarction. Br Med J 287: 324-326, 1983
73. Ockene JK, Kuller LH, Svendsen KH, et al: The relationship of smoking cessation to coronary heart disease and lung cancer in the Multiple Risk Factor Intervention Trial (MRFIT). Am J Public Health 80: 954-958, 1990
74. Vlietstra RE, Kronmal RA, Oberman A, et al: Effect of cigarette smoking on survival of patients with angiographically documented coronary artery disease. Report from the CASS registry. JAMA 255:1023-1027, 1986
75. Multiple Risk Factor Intervention Trial Research Group: Mortality rates after 10.5 years for participants in the Multiple Risk Factor Intervention Trial. Findings related to a priori hypotheses of the trial. JAMA 263:1795-1801, 1990
76. Multiple Risk Factor Intervention Trial Research Group: Mortality after 16 years for participants randomized to the Multiple Risk Factor Intervention Trial. Circulation 94:946-951, 1996
77. Rose G, Hamilton PJ, Colwell L, et al: A randomised controlled trial of anti-smoking advice: 10-year results. J Epidemiol Community Health 36:102-108, 1982
78. Njolstad I, Arnesen E, Lund-Larsen PG: Smoking, serum lipids, blood pressure, and sex differences in myocardial infarction. A 12-year follow-up of the Finnmark Study. Circulation 93:450-456, 1996
79. Al-Delaimy WK, Manson JE, Solomon CG, et al: Smoking and risk of coronary heart disease among women with type 2 diabetes mellitus. Arch Intern Med 162:273-279, 2002
80. Neaton JD, Kuller LH, Wentworth D, et al: Total and cardiovascular mortality in relation to cigarette smoking, serum cholesterol concentration, and diastolic blood pressure among black and white males followed up for five years. Am Heart J 108:759-769, 1984
81. Garfinkel L: Cigarette smoking and coronary heart disease in blacks: Comparison to whites in a prospective study. Am Heart J 108:802-807, 1984
82. Keil JE, Sutherland SE, Knapp RG, et al: Mortality rates and risk factors for coronary disease in blacks as compared with white men and women. N Engl J Med 329:73-78, 1993
83. Keil JE, Sutherland SE, Hames CG, et al: Coronary disease mortality and risk factors in black and white men. Results from the combined Charleston, SC, and Evans County, Georgia, heart studies. Arch Intern Med 155:1521-1527, 1995
84. Gillum RF: Coronary heart disease in black populations. I. Mortality and morbidity. Am Heart J 104: 839-851, 1982
85. Roig E, Castaner A, Simmons B, et al: In-hospital mortality rates from acute myocardial infarction by race in U.S. hospitals: Findings from the National Hospital Discharge Survey. Circulation 76:280-288, 1987
86. Taylor HA Jr, Mickel MC, Chaitman BR, et al: Long-term survival of African Americans in the Coronary Artery Surgery Study (CASS). J Am Coll Cardiol 29:358-364, 1997
87. Tyroler HA, Knowles MG, Wing SB, et al: Ischemic heart disease risk factors and twenty-year mortality in middle-age Evans County black males. Am Heart J 108:738-746, 1984
88. Rosenberg L, Palmer JR, Rao RS, et al: Risk factors for coronary heart disease in African American women. Am J Epidemiol 150:904-909, 1999
89. Gillum RF, Mussolino ME, Madans JH: Coronary heart disease risk factors and attributable risks in African-American women and men: NHANES I epidemiologic follow-up study. Am J Public Health 88: 913-917, 1998
90. Hames CG, Rose K, Knowles M, et al: Black-white comparisons of 20-year coronary heart disease mortality in the Evans County Heart Study. Cardiology 82:122-136, 1993
91. Mendelson G, Aronow WS, Ahn C: Prevalence of coronary artery disease, atherothrombotic brain infarction, and peripheral arterial disease: Associated risk factors in older Hispanics in an academic hospital-based geriatrics practice. J Am Geriatr Soc 46:481-483, 1998
92. Kiyohara Y, Ueda K, Fujishima M: Smoking and cardiovascular disease in the general population in Japan. J Hypertens Suppl 8:S9-S15, 1990
93. Lam TH, He Y, Shi QL, et al: Smoking, quitting, and mortality in a Chinese cohort of retired men. Ann Epidemiol 12:316-320, 2002
94. Miyake Y: Fukuoka Heart Study Group. Risk factors for non-fatal acute myocardial infarction in middle-aged and older Japanese. Jpn Circ J 64:103-109, 2000
95. Sytkowski PA, D'Agostino RB, Belanger A, et al: Sex and time trends in cardiovascular disease incidence and mortality: The Framingham Heart Study, 1950-1989. Am J Epidemiol 143:338-350, 1996
96. Thun MJ, Day-Lally CA, Calle EE, et al: Excess mortality among cigarette smokers: Changes in a 20-year interval. Am J Public Health 85:1223-1230, 1995
97. Thun M, Myers D, Day-Lallym C, et al: Trends in tobacco smoking and mortality from cigarette use in cancer prevention studies I (1959 through 1965) and II (1982 through 1988), in Changes in Cigarette-Related Disease Risks and Their Implications for Prevention and Control. Burns D, Garfinkel L, Samet JM, eds. Smoking and Tobacco Control Monograph 8. Bethesda, MD, U.S. DHHS, National Institutes of Health, National Cancer Institute, 1997, pp 305-382
98. Kelly TL, Gilpin E, Ahnve S, et al: Smoking status at the time of acute myocardial infarction and subsequent prognosis. Am Heart J 110:535-541, 1985
99. Molstad P: First myocardial infarction in smokers. Eur Heart J 12:753-759, 1991
100. Barbash GI, White HD, Modan M, et al: Significance of smoking in patients receiving thrombolytic therapy for acute myocardial infarction. Experience gleaned from the International Tissue Plasminogen Activator/Streptokinase Mortality Trial. Circulation 87:53-58, 1993
101. Gottlieb S, Boyko V, Zahger D, et al: Smoking and prognosis after acute myocardial infarction in the thrombolytic era (Israeli Thrombolytic National Survey). J Am Coll Cardiol 28:1506-1513, 1996
102. McElduff P, Dobson AJ: Case fatality after an acute cardiac event: The effect of smoking and alcohol consumption. J Clin Epidemiol 54:58-67, 2001
103. Njolstad I, Arnesen E: Preinfarction blood pressure and smoking are determinants for a fatal outcome of myocardial infarction: A prospective analysis from the Finnmark Study. Arch Intern Med 158:1326-1332, 1998
104. Herlitz J, Karlson BW, Karlsson T, et al: Predictors of death during 5 years after hospital discharge among patients with a suspected acute coronary syndrome with particular emphasis on whether an infarction was developed. Int J Cardiol 66:73-80, 1998
105. Lee PN, Garfinkel L. Mortality and type of cigarette smoked. J Epidemiol Community Health 35:16-22, 1981
106. Higenbottam T, et al: Cigarettes, lung cancer, and coronary heart disease: The effects of inhalation and tar yield. J Epidemiol Community Health 36:113-117, 1982
107. Tang JL, Morris JK, Wald NJ: Mortality in relation to tar yield of cigarettes: A prospective study of four cohorts. BMJ 311:1530-1533, 1995
108. Benhamou E, Benhamou S, Flamant R: Lung cancer and women: Results of a French case-control study. Br J Cancer 55:91-95, 1987
109. Powell JT, Edwards RJ, Worrell PC: Risk factors associated with the development of peripheral arterial disease in smokers: A case-control study. Atherosclerosis 129:41-48, 1997
110. Parish S, Collins R, Peto R: Cigarette smoking, tar yields, and non-fatal myocardial infarction: 14,000 cases and 32,000 controls in the United Kingdom. The International Studies of Infarct Survival (ISIS) Collaborators. BMJ 311:471-477, 1995
111. Woodward M: Is compulsory restriction of tar yield of cigarettes a worthwhile public health policy? Am J Prev Med 21:284-290, 2001
112. Petitti DB, Friedman GD: Cardiovascular and other diseases in smokers of low yield cigarettes. J Chron Dis 38:581-588, 1985
113. Hawthorne VM, Fry JS: Smoking and health: The association between smoking behavior, total mortality, and cardiorespiratory disease in West Central Scotland. J Epidemiol Community Health 32:260-266, 1978
114. Palmer J, Rosenberg L, Shapiro S: Low yield cigarettes and the risk of nonfatal myocardial infarction in women. N Engl J Med 320:1569-1573, 1989
115. Negri E: Tar yield of cigarettes and risk of acute myocardial infarction. BMJ 306:1567-1569, 1993
116. Borland C, Chamberlain A, Higenbottam T: Carbon monoxide yield of cigarettes and its relation to cardiorespiratory disease. BMJ 287:1583-1586, 1983
117. Todd GF, Hunt BM, Lambert PM: Four cardiorespiratory symptoms as predictors of mortality. J Epidemiol Community Health 32:267-274, 1978
118. Alderson MR, Lee PN, Wang R: Risks of lung cancer, chronic bronchitis, ischaemic heart disease, and stroke in relation to type of cigarette smoked. J Epidemiol Community Health 39:286-293, 1985
119. Benowitz NL, Hall SM, Herning RI, et al: Smokers of low-yield cigarettes do not consume less nicotine. N Engl J Med 309:139-142, 1983
120. Jarvis MJ, Boreham R, Primatesta P, et al: Nicotine yield from machine-smoked cigarettes and nicotine intakes in smokers: Evidence from a representative population survey. J Natl Cancer Inst 93:134-138, 2001
121. Stratton K, Shetty P, Wallace R, et al: Clearing the smoke. Washington, DC, National Academy Press. Assessing the science base for tobacco harm reduction, 2001
122. Scientific Advisory Committee on Tobacco Product Regulation (SACTob): Recommendation on heath claims derived from ISO/FTC method to measure cigarette smoke. Geneva, Switzerland, World Health Organization, 2002
123. Dawber TR: The Framingham Study: The epidemiology of atherosclerotic Disease. Cambridge, MA, Harvard University Press, 1980, p 267
124. Kannel WB, Thomas HE Jr: Sudden coronary death: The Framingham Study. Ann N Y Acad Sci 382:3-21, 1982
125. Wannamethee G, Shaper AG, Macfarlane PW, et al: Risk factors for sudden cardiac death in middle-aged British men. Circulation 91:1749-1756, 1995
126. Sexton PT, Walsh J, Jamrozik K, et al: Risk factors for sudden unexpected cardiac death in Tasmanian men. Aust N Z J Med 27:45-50, 1997
127. Kannel WB, Doyle JT, McNamara PM, et al: Precursors of sudden coronary death. Factors related to the incidence of sudden death. Circulation 51:606-613, 1975
128. Escobedo LG, Zack MM: Comparison of sudden and nonsudden coronary deaths in the United States. Circulation 93:2033-2036, 1996
129. Escobedo LG, Caspersen CJ: Risk factors for sudden coronary death in the United States. Epidemiology 8:175-180, 1997
130. Kagan A, Yano K, Reed DM, et al: Predictors of sudden cardiac death among Hawaiian-Japanese men. Am J Epidemiol 130:268-277, 1989
131. Cupples LA, Gagnon DR, Kannel WB: Long- and short-term risk of sudden coronary death. Circulation 85:I11-I18, 1992 suppl
132. Peters RW, Brooks MM, Todd L, et al: Smoking cessation and arrhythmic death: The CAST experience. The Cardiac Arrhythmia Suppression Trial (CAST) Investigators. J Am Coll Cardiol 26:1287-1292,1995
133. Hallstrom AP, Cobb LA, Ray R: Smoking as a risk factor for recurrence of sudden cardiac arrest. N Engl J Med 314:271-275, 1986
134. Cosgrove DM, Loop FD, Lytle BW, et al: Determinants of 10-year survival after primary myocardial revascularization. Ann Surg 202:480-490, 1985
135. Myers WO, Blackstone EH, Davis K, et al: CASS Registry long term surgical survival. Coronary Artery Surgery Study. J Am Coll Cardiol 33:488-498, 1999
136. Kazmers A, Kohler TR: Very late survival after vascular surgery. J Surg Res 105:109-114, 2002
137. Herlitz J, Haglid M, Albertsson P, et al: Short- and long-term prognosis after coronary artery bypass grafting in relation to smoking habits. Cardiology 88:492-497, 1997
138. Van Brussel BL, Plokker HW, Voors AA, et al: Multivariate risk factor analysis of clinical outcome 15 years after venous coronary artery bypass graft surgery. Eur Heart J 16:1200-1206, 1995
139. Cavender JB, Rogers WJ, Fisher LD, et al: Effects of smoking on survival and morbidity in patients randomized to medical or surgical therapy in the Coronary Artery Surgery Study (CASS): 10-year follow-up. CASS Investigators. J Am Coll Cardiol 20:287-294, 1992
140. Arora RR, Konrad K, Badhwar K, et al: Restenosis after transluminal coronary angioplasty: A risk factor analysis. Cathet Cardiovasc Diagn 19:17-22, 1990
141. Violaris AG, Thury A, Regar E, et al: Influence of a history of smoking on short term (six month) clinical and angiographic outcome after successful coronary angioplasty. Heart 84:299-306, 2000
142. Cohen DJ, Doucet M, Cutilp DE, et al: Impact of smoking on clinical and angiographic restenosis after percutaneous coronary intervention: Another smoker's paradox? Circulation 104:773-778, 2001
143. Cutlip DE, Chauhan MS, Baim DS, et al: Clinical restenosis after coronary stenting: Perspectives from multicenter clinical trials. J Am Coll Cardiol 40:2082-2089, 2002
144. Colditz GA, Bonita R, Stampfer MJ, et al: Cigarette smoking and risk of stroke in middle-aged women. N Engl J Med 318:937-941, 1988
145. Wolf PA, D'Agostino RB, Kannel WB, et al: Cigarette smoking as a risk factor for stroke. The Framingham Study. JAMA 259:1025-1029, 1988
146. Kannel WB, Higgins M: Smoking and hypertension as predictors of cardiovascular risk in population studies. J Hypertens 8:S3-S8, 1990 (Suppl)
147. Haheim LL, Holme I, Hjermann I, et al: Smoking habits and risk of fatal stroke: 18 years follow up of the Oslo Study. J Epidemiol Community Health 50: 621-624, 1996
148. Tanne D, Yaari S, Goldbourt U: Risk profile and prediction of long-term ischemic stroke mortality: A 21-year follow-up in the Israeli Ischemic Heart Disease (IIHD) Project. Circulation 98:1365-1371, 1998
149. Sharrett AR, Sorlie PD, Chambless LE, et al: Relative importance of various risk factors for asymptomatic carotid atherosclerosis versus coronary heart disease incidence: The Atherosclerosis Risk in Communities Study. Am J Epidemiol 149:843-852, 1999
150. Djousse L, Myers RH, Province MA, et al: Influence of apolipoprotein E, smoking, and alcohol intake on carotid atherosclerosis: National Heart, Lung, and Blood Institute Family Heart Study. Stroke 33:1357-1361, 2002
151. Hart CL, Hole DJ, Smith GD: Risk factors and 20-year stroke mortality in men and women in the Renfrew/Paisley study in Scotland. Stroke 30:1999-2007, 1999
152. Shinton R, Beevers G: Meta-analysis of relation between cigarette smoking and stroke. BMJ 298:789-794, 1989
153. Kawachi I, Colditz GA, Stampfer MJ, et al: Smoking cessation and decreased risk of stroke in women. JAMA 269:232-236, 1993
154. Salonen R, Salonen JT: Determinants of carotid intima-media thickness: A population-based ultrasonography study in eastern Finnish men. J Intern Med 229:225-231, 1991
155. Salonen R, Salonen JT: Progression of carotid atherosclerosis and its determinants: A population-based ultrasonography study. Atherosclerosis 81: 33-40, 1990
156. Howard G, Burke GL, Szklo M, et al: Active and passive smoking are associated with increased carotid wall thickness. The Atherosclerosis Risk in Communities Study. Arch Intern Med 154:1277-1282, 1994
157. Salonen R, Tervahauta M, Salonen JT, et al: Ultrasonographic manifestations of common carotid atherosclerosis in elderly eastern Finnish men. Prevalence and associations with cardiovascular diseases and risk factors. Arterioscler Thromb 14:1631-1640, 1994
158. Ebrahim S, Papacosta O, Whincup P, et al: Carotid plaque, intima media thickness, cardiovascular risk factors, and prevalent cardiovascular disease in men and women: The British Regional Heart Study. Stroke 30:841-850, 1999
159. Ferrieres J, Elias A, Ruidavets JB, et al: Carotid intima-media thickness and coronary heart disease risk factors in a low-risk population. J Hypertens 17:743-748, 1999
160. Fine-Edelstein JS, Wolf PA, O'Leary DH, et al: Precursors of extracranial carotid atherosclerosis in the Framingham Study. Neurology 44:1046-1050, 1994
161. Poredos P, Orehek M, Tratnik E: Smoking is associated with dose-related increase of intima-media thickness and endothelial dysfunction. Angiology 50:201-208, 1999
162. Weber F: Risk factors for subclinical carotid atherosclerosis in healthy men. Neurology 59:524-528, 2002
163. Diez-Roux AV, Nieto FJ, Comstock GW, et al: The relationship of active and passive smoking to carotid atherosclerosis 12-14 years later. Prev Med 24:48-55, 1995
164. Crouse JR 3rd, Tang R, Espeland MA, et al: Associations of extracranial carotid atherosclerosis progression with coronary status and risk factors in patients with and without coronary artery disease. Circulation 106;2061-2066, 2002
165. Chambless LE, Folsom AR, Davis V, et al: Risk factors for progression of common carotid atherosclerosis: The Atherosclerosis Risk in Communities Study, 1987-1998. Am J Epidemiol 155:38-47, 2002
166. Mathiesen EB, Joakimsen O, Bonaa KH: Prevalence of and risk factors associated with carotid artery stenosis: The Tromso Study. Cerebrovasc Dis 12: 44-51, 2001
167. Csanyi A, Egervari A, Nagy Z: Influence of hypertension and smoking as the single vascular risk factors on the intima-media thickness. Eur J Epidemiol 17: 855-861, 2001
168. Liang YL, Shiel LM, Teede H, et al: Effects of blood pressure, smoking, and their interaction on carotid artery structure and function. Hypertension 37:6-11, 2001
169. Aminbakhsh A, Frohlich J, Mancini GB: Detection of early atherosclerosis with B mode carotid ultrasonography: Assessment of a new quantitative approach. Clin Invest Med. 22:265-274, 1999
170. Lassila HC, Tyrrell KS, Matthews KA, et al: Prevalence and determinants of carotid atherosclerosis in healthy postmenopausal women. Stroke 28:513-517, 1997
171. Hammond EC, Horn D: Smoking and death rates: Report on forty-four months of follow-up of 187,783 men. 2. Death rates by cause. JAMA 166:1294-308, 1958
172. Weir JM, Dunn JE Jr: Smoking and mortality: A prospective study. Cancer 25:105-112, 1970
173. Strachan DP: Predictors of death from aortic aneurysm among middle-aged men: The Whitehall study. Br J Surg 78:401-404, 1991
174. a. Nillson S, Carstensen JM, Pershagen G: Mortality among male and female smokers in Sweden: a 33 year follow-up. J Epidemiol Comm Health 55:825-830, 2001
175. Kahn HA: The Dorn study of smoking and mortality among U.S. veterans: Report on 8 and one-half years of observation, in Haenszel W (ed): Epidemiological Approaches to the Study of Cancer and Other Chronic Diseases. Atlanta, GA, National Cancer Institute Monograph No. 19, U.S. Department of Health, Education, and Welfare, Public Health Service, National Institutes of Health, National Cancer Institute, pp 1-125, 1966
176. Hammond EC, Garfinkel L: Coronary heart disease, stroke, and aortic aneurysm. Factors in the etiology. Arch Environ Health 19:167-182, 1969
177. Vardulaki KA, Walker NM, Day NE, et al: Quantifying the risks of hypertension, age, sex and smoking in patients with abdominal aortic aneurysm. Br J Surg 87:195-200, 2000
178. Blanchard JF, Armenian HK, Friesen PP: Risk factors for abdominal aortic aneurysm: Results of a case-control study. Am J Epidemiol 151:575-583, 2000
179. Alcorn HG, Wolfson SK Jr, Sutton-Tyrrell K, et al: Risk factors for abdominal aortic aneurysms in older adults enrolled in The Cardiovascular Health Study. Arterioscler Thromb Vasc Biol 16:963-970, 1996
180. Lee AJ, Fowkes FG, Carson MN, et al: Smoking, atherosclerosis and risk of abdominal aortic aneurysm. Eur Heart J 18:671-676, 1997
181. Wilmink TB, Quick CR, Day NE: The association between cigarette smoking and abdominal aortic aneurysms. J Vasc Surg 30:1099-1105, 1999
182. Lederle FA, Johnson GR, Wilson SE: Abdominal aortic aneurysm in women. J Vasc Surg 34:122-126, 2001
183. Jamrozik K, Norman PE, Spencer CA, et al: Screening for abdominal aortic aneurysm: Lessons from a population-based study. Med J Aust 173:345-350, 2000
184. Witteman JC, Grobbee DE, Valkenburg HA, et al: Cigarette smoking and the development and progression of aortic atherosclerosis. A 9-year population-based follow-up study in women. Circulation 88:2156-2162, 1993
185. Lindholt JS, Heegaard NH, Vammen S, et al: Smoking, but not lipids, lipoprotein(a) and antibodies against oxidised LDL, is correlated to the expansion of abdominal aortic aneurysms. Eur J Vasc Endovasc Surg 21:51-56, 2001
186. Tornwall ME, Virtamo J, Haukka JK, et al: Life-style factors and risk for abdominal aortic aneurysm in a cohort of Finnish male smokers. Epidemiology 12: 94-100, 2001
187. Aragon D, Clancy R, Sole ML, et al: Variables influencing patients' outcomes after elective aortic reconstruction surgery. Am J Crit Care 9:279-287, 2000
188. Brown LC, Powell JT: Risk factors for aneurysm rupture in patients kept under ultrasound surveillance. UK Small Aneurysm Trial Participants. Ann Surg 230:289-297, 1999
189. Weiss NS: The value of roentgenographic abdominal aortic calcification in predicting site of occlusion in arteriosclerosis obliterans. Angiology 23:136-139, 1972
190. Kannel WB, Shurtleff D: The Framingham Study. Cigarettes and the development of intermittent claudication. Geriatrics 28:61-68, 1973
191. Wilt TJ, Davis BR, Meyers DG, et al: Prevalence and correlates of symptomatic peripheral atherosclerosis in individuals with coronary heart disease and cholesterol levels less than 240 mg/dL: Baseline results from the Cholesterol and Recurrent Events (CARE) Study. Angiology 47:533-541, 1996
192. Price JF, Mowbray PI, Lee AJ, et al: Relationship between smoking and cardiovascular risk factors in the development of peripheral arterial disease and coronary artery disease: Edinburgh Artery Study. Eur Heart J 20:344-353, 1999
193. Meijer WT, Grobbee DE, Hunink MG, et al: Determinants of peripheral arterial disease in the elderly: The Rotterdam study. Arch Intern Med 160:2934-2938, 2000
194. Ness J, Aronow WS, Ahn C: Risk factors for symptomatic peripheral arterial disease in older persons in an academic hospital-based geriatrics practice. J Am Geriatr Soc 48:312-314, 2000
195. Hooi JD, Stoffers HE, Kester AD, et al: Risk factors and cardiovascular diseases associated with asymptomatic peripheral arterial occlusive disease. The Limburg PAOD Study. Peripheral Arterial Occlusive Disease. Scand J Prim Health Care 16:177-182, 1998
196. Palumbo PJ, O'Fallon WM, Osmundson PJ, et al: Progression of peripheral occlusive arterial disease in diabetes mellitus. What factors are predictive? Arch Intern Med 151:717-721, 1991
197. Bowlin SJ, Medalie JH, Flocke SA, et al: Epidemiology of intermittent claudication in middle-aged men. Am J Epidemiol 140:418-430, 1994
198. Murabito JM, Evans JC, Nieto K, et al: Prevalence and clinical correlates of peripheral arterial disease in the Framingham Offspring Study. Am Heart J 143:961-965, 2002
199. Fowkes FG, Housley E, Riemersma RA, et al: Smoking, lipids, glucose intolerance, and blood pressure as risk factors for peripheral atherosclerosis compared with ischemic heart disease in the Edinburgh Artery Study. Am J Epidemiol 135:331-340, 1992
200. Fowler B, Jamrozik K, Norman P, et al: Prevalence of peripheral arterial disease: Persistence of excess risk in former smokers. Aust N Z J Public Health 26:219-224, 2002
201. Fowler B, Jamrozik K, Norman P, et al: Improving maximum walking distance in early peripheral arterial disease: Randomised controlled trial. Aust J Physiother 48:269-275, 2002
202. Juergens JL, Barker NW, Hines EA: Arteriosclerosis obliterans: Review of 20 cases with special reference to pathogenic and prognostic factors. Circulation 21:188-195, 1960
203. Birkenstock WE, Louw JH, Terblanche J, et al: Smoking and other factors affecting the conservative management of peripheral vascular disease. S Afr Med J 49:1129-1132, 1975
204. Wray R, DePalma RG, Hubay CH: Late occlusion of aortofemoral bypass grafts: Influence of cigarette smoking. Surgery 70:969-973, 1971
205. Myers KA, King RB, Scott DF, et al: The effect of smoking on the late patency of arterial reconstructions in the legs. Br J Surg 65:267-271, 1978
206. Ameli FM, Stein M, Provan JL, et al: The effect of postoperative smoking on femoropopliteal bypass grafts. Ann Vasc Surg 3:20-25, 1989
207. Wiseman S, Kenchington G, Dain R, et al: Influence of smoking and plasma factors on patency of femoropopliteal vein grafts. BMJ 299:643-646, 1989
208. National Cancer Institute: Cigar smoking in the United States: Health effects and trends, in Burns D, Cummings KM, Hoffman D, Smoking and Tobacco Control Monograph No. 9. Atlanta, GA, U.S. Department of Health and Human Services, National Institutes of Health, National Cancer Institute, 1998
209. Shanks T, Burns D: Disease consequences of cigar smoking, in Burns D, Cummings KM, Hoffman D, Cigar Smoking in the United States: Health Effects and Trends. Smoking and Tobacco Control Monograph No. 9. Atlanta, GA, U.S. Department of Health and Human Services, National Institutes of Health, National Cancer Institute, 1998
210. Jacobs EJ, Thun MJ, Apicella LF: Cigar smoking and death from coronary heart disease in a prospective study of US men. Arch Intern Med 159:2413-2418, 1999
211. Iribarren C, Tekawa IS, Sidney S, et al: Effect of cigar smoking on the risk of cardiovascular disease, chronic obstructive pulmonary disease, and cancer in men. N Engl J Med 340:1773-1780, 1999
212. Baker F, Ainsworth SR, Dye JT, et al: Health risks associated with cigar smoking. JAMA 284:735-740, 2000